MEDNAX, INC.
NYSE: MD
▲
24.25
+0.32
+1.34%
Operating Income
-1.14B
Operating Margin
-32.33
- Income Statement
- Balance Sheet
- Cash Flow
- Annual
- Quarterly
-
Values in Millions (Except for per share items)
-
2017
-
2018
-
2019
-
Period End Date
-
12/31/2017
-
12/31/2018
-
12/31/2019
-
Stmt Source
-
Annual
-
Annual
-
Annual
-
Stmt Source Date
-
12/31/2019
-
12/31/2019
-
12/31/2019
-
Stmt Update Type
-
-
-
-
-
-
-
Currency Code
-
Total Revenue
-
3,253.4
-
3,454.8
-
3,513.5
-
Cost of Revenue
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
Selling,General and Administrative
-
2,613.2
-
2,830.3
-
2,913.4
-
Research and Development
-
-
-
-
-
-
-
Special Income/Charges
-
0.0
-
0.0
-
-1,544.5
-
Operating Expenses
-
2,798.5
-
3,023.0
-
4,649.6
-
Operating Income
-
454.9
-
431.8
-
-1,136.0
-
Net Interest Income
-
-
-
-
-
-
-
Other Income/Expense,Net
-
-
-
-
-
-
-
Pre-Tax Income
-
385.7
-
355.1
-
-1,242.0
-
Provision for Income Tax
-
-
-
-
-
-
-
Net Income
-
320.4
-
268.6
-
-1,497.7
-
Dividend Per Share
-
-
-
-
-
-
-
Tax Rate
-
20.8029
-
27.165
-
Basic EPS
-
3.47
-
2.95
-
-17.94
-
Diluted EPS
-
3.29
-
2.82
-
-13.77